@article {1438, title = {Hepatoprotective effect of Livplus- A polyherbal formulation}, journal = {Pharmacognosy Journal}, volume = {7}, year = {2015}, month = {9th June 2015}, pages = {4-4}, type = {Original Article}, chapter = {4}, abstract = {

Nill

}, keywords = {Acetylcholine, Antitussive, Bronchoprotection, Citric acid, Cough, Cough variant asthma (CVA), Ethanolic extract of Woodfordia fruticosa (L.) Kurz (EEWF), Histamine.}, author = {Rajesh A Maheshwari, and Bhagyashree Pandya and R. Balaraman, Avinash K Seth and Yogesh Chand and Yadav and Vasa Siva Sankar} } @article {1484, title = {Antianaphylactic, mast cell stabilizing and antiasthmatic activity of AHR-1 (a polyherbal formulation)}, journal = {Pharmacognosy journal}, volume = {6}, year = {2014}, month = {8th April 2014}, pages = {93-99}, type = {Original Article}, abstract = {

Objective: This work was mainly aimed to study the anti-anaphylactic, mast cell stabilizing and antiasthmatic activity of AHR-1 (a polyherbal formulation) which contain various herbal extracts. Methods: The antianaphylactic activity of AHR-1 was evaluated in rats using active anaphylaxis model. Rats were then observed for onset of symptoms of anaphylaxis reaction such as increased respiratory rate, dyspnea, cyanosis and mortality. Serum IgE, leukocyte, eosinophil countand \% polymorphs were calculated. Mast cell stabilizing effect was investigated by in vitro challenge of antigensensitized rat intestinal mesenteries. Antiasthmatic effect wasstudied in guinea pigs using histamine-induced bronchospasm, in which occurrence of preconvulsive dyspnea (PCD) was noted as end point. Results: Anaphylactic shock caused by intravenous antigen challenge showed 83\% mortality with a significant (P\<0.001) increaserespiratory symptom score.Treatment with AHR-1(250 and 500 mg/kg) reduced the mortality and respiratory symptom score (P\<0.05, P\<0.001), respectively. AHR- 1 (250 and 500 mg/kg) significantly and dose dependently decreased Serum IgE (P\<0.05, P\<0.001), AEC (P\<0.05, P\<0.001), total leukocytes (P\<0.05, P\<0.01) and \% polymorphs (P\<0.01,P\<0.001), respectively as compared to sensitized control group. Sensitized control rats wereproduced a significant (79\%) mesenteric mast cell degranulation, but pre-treatment with AHR-1 (100 and 200\μg/ml) produced in a significant (p\<0.001) reduction in the number of degranulated mast cells when challenged with horse serum. AHR-1 significantly increased the time of PCD (P\<0.001) as compared to control. Conclusion: From these finding, we concluded thatAHR-1 is might be effective in treatment various hypersensitivity reactions like anaphylactic shock and asthma.

Key words: Horse serum, AHR-1, IgE, Respiratory score.

}, keywords = {AHR-1, gE, Horse serum, Respiratory score}, author = {Rajesh A Maheshwari, and R Balaraman, and GirishU Sailo, and Ghanshyam R Parmar, and Manoj Patel, and A K Seth} }